Author

Na Chen

Observed name: Na CHEN

Institutions: Nankai University, Tianjin First Center Hospital

Observed institutions: Binzhou Medical University, Nankai University, Tianjin First Center Hospital, Binzhou Medical College Hospital, Shandong Provincial Hospital, Center for Life Sciences, Shandong First Medical University, Tsinghua University

ORCID: 0000-0001-8460-6875

Observed ORCID: 0000-0001-8460-6875

OpenAlex ID: A5031332573

Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications

2021 · Nan Xiao, Meng Nie, et al. · Nature Communications · 302

Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma

2021 · Meng Nie, Ke Yao, et al. · Nature Communications · 128

Targeting acetylcholine signaling modulates persistent drug tolerance in EGFR-mutant lung cancer and impedes tumor relapse

2022 · Meng Nie, Na Chen, et al. · Journal of Clinical Investigation · 80

The unique characteristics and risk factors of enlarged perivascular spaces in pediatric moyamoya disease

2025 · Xiaoming Hou, Feng Xue, et al. · Quantitative Imaging in Medicine and Surgery · 2

Flurbiprofen axetil preemptive analgesia for patients undergoing laparoscopic cholecystotomy: a clinical observation

2015 · An-ning HUANG, Li-ping LIU, et al. · Academic Journal of Second Military Medical University · 1

The TAF3/SREBP2/cholesterol axis drives tumor progression in hepatocellular carcinoma

2026 · Jiali Qiu, Lei Cao, et al. · Clinical and Experimental Medicine

Efficacy of budesonide suspension in the treatment of lobar pneumonia by fiberoptic bronchoscopic alveolar lavage

2025 · Xin Ji, Hongjie Fu, et al. · Frontiers in Medicine

Works count: 7

Citation count: 512

H-index: 3

I10-index: 3